Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 18/20 | 0.67 |
| ▸ | SCN8A | Q9UQD0 | 18/20 | 0.67 |
| ▸ | SCN5A | Q14524 | 15/20 | 0.67 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21783453 | 0.81 | SCN1A (0.49) | SCN1ASCN8ASCN5A | |
| SCHEMBL21783524 | 0.80 | SCN1A (1.00) | SCN1ASCN8ASCN5A | |
| SCHEMBL20256172 | 0.77 | SCN1A (0.70) | SCN1ASCN8ASCN5A | |
| Formic Acid SCHEMBL30047265 | 0.77 | SCN1A (0.92) | SCN1ASCN8ASCN5A | |
| Formic Acid SCHEMBL21955463 | 0.77 | SCN1A (0.92) | SCN1ASCN8ASCN5A | |
| SCHEMBL21783533 | 0.76 | SCN8A (0.53) | SCN1ASCN8ASCN5A | |
| SCHEMBL21783328 | 0.72 | SCN1A (0.70) | SCN1ASCN8ASCN5A | |
| SCHEMBL21783335 | 0.72 | SCN8A (0.69) | SCN1ASCN8ASCN5A | |
| SCHEMBL21783422 | 0.71 | SCN1A (0.71) | SCN1ASCN8ASCN5A | |
| SCHEMBL21955464 | 0.71 | SCN1A (0.66) | SCN1ASCN8ASCN5AMAPK8MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020047323-A1 | HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2020-03-05 | — | — | WO | disclosed |